Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Sheng Lin-Gibson (Fed)
Dr. Sheng Lin-Gibson is the Chief of the Biosystems and Biomaterials Division (BBD) at the National Institute of Standards and Technology (NIST). BBD has a multidisciplinary technical portfolio that includes genomic measurements, synthetic biology, regenerative medicine and advanced therapies, biomaterials, diagnostics, and complex microbial systems. BBD carries out its mission through fundamental research in measurement science, the development of new technologies, and the deployment of new measurement solutions, including reference materials and data.
More information about BBD:
About BBD
Core capabilities
Primary focus areas
Standards and reference materials
Honors and Awards
- Gears of Government Award: Biotechnology Standards Leadership (2019)
- Department of Commerce (DoC) Gold Medal Award: Biotechnology Standards Leadership (2019)
- Department of Commerce (DoC) Bronze Medal: Cell Counting Measurements (2017)
- Department of Commerce (DoC) Bronze Medal: Metrology for Dental Materials (2014)
- NIST Sigma Xi Young Investigator Award (2011)
- National Academy of Engineering (NAE) China-America Frontiers of Engineering (2011)
- Department of Commerce (DoC) Bronze Medal: Combinatorial Testing of Biomaterials (2010)
- NIST/NRC Postdoctoral Research Fellowship
Selected Publications: (Out of 200+ Publications)
S. Lin-Gibson and V. Srinivasan, "Recent Industrial Roadmaps to Enable Smart Manufacturing of Biopharmaceuticals," IEEE Transactions on Automation Science and Engineering, doi: 10.1109/TASE.2019.2951018.
K Czechowska, J Lannigan, L Wang, J Arcidiacono et al, Cyt‐Geist: Current and Future Challenges in Cytometry: Reports of the CYTO 2018 Conference Workshops,” Cytometry Part A, 2019, 95(6), 598-644.
S Sarkar, L Pierce, S Lin-Gibson, SP Lund, “Standards landscape in cell counting: implications for cell & gene therapy” Cell Gene Ther. Insights, 2019, 5 (1), 117-31
S Sarkar, S Lin‐Gibson, "Computational Design of Photocured Polymers Using Stochastic Reaction–Diffusion Simulation” Advanced Theory and Simulations, 2018, 1(7), 1800028
J.A. Arcidiacono, S.R. Bauer, D.S. Kaplan, C.M. Allocca, S. Sarkar, S. Lin-Gibson, “FDA and NIST collaboration on standards development activities supporting innovation and translation of regenerative medicine products,” Cytotherapy, 2018, 20 (6), 779-784.
S Lin-Gibson, S Sarkar, JT Elliott, “Summary of the National Institute of Standards and Technology and US Food And Drug Administration cell counting workshop: Sharing practices in cell counting measurements”, Cytotherapy, 2018, 20 (6), 785-795.
S Sarkar, SP Lund, R Vyzasatya, P Vanguri, JT Elliott, AL Plant “Evaluating the quality of a cell counting measurement process via a dilution series experimental design,” 2017, Cytotherapy 19 (12), 1509-1521.
D López Pérez, PJ Baker, AL Pintar, J Sun, NJ Lin, S Lin-Gibson, “Experimental and statistical methods to evaluate antibacterial activity of a quaternary pyridinium salt on planktonic, biofilm-forming, and biofilm states,” Biofouling 33 (3), 222-234.
S Lin-Gibson, B Hanrahan, S Matosevic, A Schnitzler, J Zhang, ...”Points to consider for cell manufacturing equipment and components” Cell Gene Therapy Insights, 2017, 3 (10), 793-805.
S Lin-Gibson, S Sarkar, Y Ito, “Defining quality attributes to enable measurement assurance for cell therapy products” Cytotherapy, 2016, 18 (10), 1241-1244.
CG Simon Jr, S Lin-Gibson, JT Elliott, S Sarkar, AL Plant “Strategies for achieving measurement assurance for cell therapy products,” Stem Cells Translational Medicine, 2016, 5 (6), 705-708